August 29, 2025
Pharmaceutical process development is not a static undertaking. Regulatory expectations continue to evolve, demanding deeper process understanding, enhanced control strategies, and comprehensive documentation throughout the development lifecycle. For companies aiming to bring new therapies to market efficiently and compliantly, staying aligned with these changes is both a challenge and an […]
August 27, 2025
The global animal health market is evolving rapidly, with innovation driven by biotech startups, established veterinary companies, and crossovers from the human pharma space. For companies looking to expand their portfolio, licensing and acquisition remain two of the most efficient ways to bring new products to market without starting from […]
August 27, 2025
For companies developing new animal health products in the United States, understanding the transition from Investigational New Animal Drug (INAD) to New Animal Drug Application (NADA) is key to regulatory success. While these acronyms may seem similar, they represent two distinct phases in the veterinary drug development process—one focused on […]
August 26, 2025
From Kansas City to Columbia, the U.S. Animal Health Corridor is home to the largest concentration of animal health companies in the world. With over 300 animal health businesses and research organizations, this region has become a global hub for innovation, partnerships, and investment in veterinary medicine. For emerging sponsors, […]
August 26, 2025
Pharmaceutical supply chains have never been under more scrutiny. From global raw material shortages and transportation bottlenecks to sudden shifts in regulatory requirements, today’s drug manufacturers face a range of logistical vulnerabilities that can disrupt development and production. These risks are not just operational they directly impact patient access, regulatory […]
May 7, 2025
Introduction In the veterinary pharmaceutical and biologics industry, Chemistry, Manufacturing, and Controls (CMC) play a crucial role in ensuring product safety, efficacy, and regulatory compliance. CMC encompasses the critical steps involved in drug development, from formulation and manufacturing processes to stability testing and quality control. As regulatory agencies such as […]
